Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells

Virology

Volumn 398, Issue 2, 2010, Pages 158-167

  Tovar Salazar, Adriana ^a   Patterson Bartlett, Julie ^a   Jesser, Renee ^a   Weinberg, Adriana ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cell mediated immunity; Cytomegalovirus; HIV infection; Regulatory T cells

Indexed keywords

CELL PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; PERFORIN; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN PD 1 LIGAND; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ CD27- CD28- T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL SELECTION; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VIRUS INHIBITION;

ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, CD28; ANTIGENS, CD4; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES; FORKHEAD TRANSCRIPTION FACTORS; GRANZYMES; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

CYTOMEGALOVIRUS;

EID: 75849128842     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.038     Document Type: Article

References (70)

1. Aandahl E.M., Michaelsson J., Moretto W.J., Hecht F.M., and Nixon D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78 5 (2004) 2454-2459
2. Adeegbe D., Bayer A.L., Levy R.B., and Malek T.R. Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J. Immunol. 176 12 (2006) 7149-7153
3. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., Ziegler S.F., Roncarolo M.G., and Levings M.K. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115 11 (2005) 3276-3284
4. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Wurzner R., Schonitzer D., and Grubeck-Loebenstein B. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 79 6 (2005) 3675-3683
5. Bekker V., Bronke C., Scherpbier H.J., Weel J.F., Jurriaans S., Wertheim-van Dillen P.M., van Leth F., Lange J.M., Tesselaar K., van Baarle D., and Kuijpers T.W. Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children. Aids 19 10 (2005) 1025-1034
6. Beyer M., Kochanek M., Giese T., Endl E., Weihrauch M.R., Knolle P.A., Classen S., and Schultze J.L. In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood 107 10 (2006) 3940-3949
7. Broderick L., and Bankert R.B. Membrane-associated TGF-beta1 inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments. J. Immunol. 177 5 (2006) 3082-3088
8. Bronke C., Jansen C.A., Westerlaken G.H., De Cuyper I.M., Miedema F., Tesselaar K., and van Baarle D. Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease. Clin. Immunol 124 2 (2007) 190-199
9. Brooks D.G., McGavern D.B., and Oldstone M.B. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J. Clin. Invest. 116 6 (2006) 1675-1685
10. Casazza J.P., Betts M.R., Price D.A., Precopio M.L., Ruff L.E., Brenchley J.M., Hill B.J., Roederer M., Douek D.C., and Koup R.A. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 203 13 (2006) 2865-2877
11. Chemnitz J.M., Eggle D., Driesen J., Classen S., Riley J.L., Debey-Pascher S., Beyer M., Popov A., Zander T., and Schultze J.L. RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma. Blood 110 9 (2007) 3226-3233
12. Chougnet C.A., and Shearer G.M. Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop. AIDS Res. Hum. Retroviruses 23 7 (2007) 945-952
13. Classen S., Zander T., Eggle D., Chemnitz J.M., Brors B., Buchmann I., Popov A., Beyer M., Eils R., Debey S., and Schultze J.L. Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions. J. Immunol. 178 11 (2007) 6931-6940
14. Curiel T.J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Krzysiek R., Knutson K.L., Daniel B., Zimmermann M.C., David O., Burow M., Gordon A., Dhurandhar N., Myers L., Berggren R., Hemminki A., Alvarez R.D., Emilie D., Curiel D.T., Chen L., and Zou W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9 5 (2003) 562-567
15. Curotto de Lafaille M.A., Lino A.C., Kutchukhidze N., and Lafaille J.J. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173 12 (2004) 7259-7268
16. Deayton J.R., Prof Sabin C.A., Johnson M.A., Emery V.C., Wilson P., and Griffiths P.D. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363 9427 (2004) 2116-2121
17. Estes J.D., Li Q., Reynolds M.R., Wietgrefe S., Duan L., Schacker T., Picker L.J., Watkins D.I., Lifson J.D., Reilly C., Carlis J., and Haase A.T. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect Dis. 193 5 (2006) 703-712
18. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., and Neurath M.F. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172 9 (2004) 5149-5153
19. Filaci G., Fenoglio D., Fravega M., Ansaldo G., Borgonovo G., Traverso P., Villaggio B., Ferrera A., Kunkl A., Rizzi M., Ferrera F., Balestra P., Ghio M., Contini P., Setti M., Olive D., Azzarone B., Carmignani G., Ravetti J.L., Torre G., and Indiveri F. CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J. Immunol. 179 7 (2007) 4323-4334
20. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 4 (2005) 331-337
21. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., and Noelle R.J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174 4 (2005) 1783-1786
22. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., and Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104 9 (2004) 2840-2848
23. Hansen W., Loser K., Westendorf A.M., Bruder D., Pfoertner S., Siewert C., Huehn J., Beissert S., and Buer J. G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J. Immunol. 177 1 (2006) 209-215
24. Haribhai D., Lin W., Relland L.M., Truong N., Williams C.B., and Chatila T.A. Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 178 5 (2007) 2961-2972
25. Hooper M., Kallas E.G., Coffin D., Campbell D., Evans T.G., and Looney R.J. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J. Rheumatol. 26 7 (1999) 1452-1457
26. Jesser R.D., Li S., and Weinberg A. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation. Virology 352 2 (2006) 408-417
27. Joffre O., Santolaria T., Calise D., Al Saati T., Hudrisier D., Romagnoli P., and van Meerwijk J.P. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14 1 (2008) 88-92
28. Jonuleit H., and Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171 12 (2003) 6323-6327
29. Khan N., Hislop A., Gudgeon N., Cobbold M., Khanna R., Nayak L., Rickinson A.B., and Moss P.A. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173 12 (2004) 7481-7489
30. Kinter A.L., Horak R., Sion M., Riggin L., McNally J., Lin Y., Jackson R., O'Shea A., Roby G., Kovacs C., Connors M., Migueles S.A., and Fauci A.S. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res. Hum. Retroviruses 23 3 (2007) 438-450
31. Knoechel B., Lohr J., Kahn E., Bluestone J.A., and Abbas A.K. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202 10 (2005) 1375-1386
32. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 12 (2005) 1219-1227
33. Levin M.J., Rinaldo Jr. C.R., Leary P.L., Zaia J.A., and Hirsch M.S. Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J. Infect Dis. 140 6 (1979) 851-857
34. Li S., Gowans E.J., Chougnet C., Plebanski M., and Dittmer U. Natural regulatory T cells and persistent viral infection. J. Virol. 82 1 (2008) 21-30
35. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., Soper D.M., Ziegler S.F., and Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J. Exp. Med. 203 7 (2006) 1701-1711
36. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., Levine S.S., Fraenkel E., von Boehmer H., and Young R.A. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445 7130 (2007) 931-935
37. Mateo V., Menager M., de Saint-Basile G., Stolzenberg M.C., Roquelaure B., Andre N., Florkin B., le Deist F., Picard C., Fischer A., and Rieux-Laucat F. Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes. Blood 110 13 (2007) 4285-4292
38. Mekala D.J., Alli R.S., and Geiger T.L. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 102 33 (2005) 11817-11822
39. Nilsson J., Boasso A., Velilla P.A., Zhang R., Vaccari M., Franchini G., Shearer G.M., Andersson J., and Chougnet C. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108 12 (2006) 3808-3817
40. Pardo J., Bosque A., Brehm R., Wallich R., Naval J., Mullbacher A., Anel A., and Simon M.M. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. J. Cell Biol. 167 3 (2004) 457-468
41. Pourgheysari B., Khan N., Best D., Bruton R., Nayak L., and Moss P.A. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J. Virol. 81 14 (2007) 7759-7765
42. Raimondi G., Shufesky W.J., Tokita D., Morelli A.E., and Thomson A.W. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J. Immunol. 176 5 (2006) 2808-2816
43. Rao P.E., Petrone A.L., and Ponath P.D. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J. Immunol. 174 3 (2005) 1446-1455
44. Rubtsov Y.P., and Rudensky A.Y. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7 6 (2007) 443-453
45. Sandner S.E., Clarkson M.R., Salama A.D., Sanchez-Fueyo A., Domenig C., Habicht A., Najafian N., Yagita H., Azuma M., Turka L.A., and Sayegh M.H. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 174 6 (2005) 3408-3415
46. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., and Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203 7 (2006) 1693-1700
47. Selvaraj R.K., and Geiger T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 179 2 (2007) 11 p following 1390
48. Sharpe A.H., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8 3 (2007) 239-245
49. Shevach E.M., and Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?. Nat. Rev. Immunol. 6 8 (2006) 613-618
50. Smyk-Pearson S., Golden-Mason L., Klarquist J., Burton J.R., Tester I.A., Wang C.C., Culbertson N., Vandenbark A.A., and Rosen H.R. Functional suppression by FoxP3(+)CD4(+)CD25(high) regulatory T cells during acute hepatitis C virus infection. J. Infect Dis. 197 1 (2008) 46-57
51. Stephens G.L., Andersson J., and Shevach E.M. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 178 11 (2007) 6901-6911
52. Suffia I.J., Reckling S.K., Piccirillo C.A., Goldszmid R.S., and Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203 3 (2006) 777-788
53. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., Sleath P.R., Grabstein K.H., Hosken N.A., Kern F., Nelson J.A., and Picker L.J. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202 5 (2005) 673-685
54. Thomas D.A., and Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8 5 (2005) 369-380
55. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., and Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9 2 (2008) 194-202
56. van de Berg P.J., van Stijn A., Ten Berge I.J., and van Lier R.A. A fingerprint left by cytomegalovirus infection in the human T cell compartment. J. Clin. Virol. 41 3 (2008) 213-217
57. van Leeuwen E.M., Remmerswaal E.B., Vossen M.T., Rowshani A.T., Wertheim-van Dillen P.M., van Lier R.A., and ten Berge I.J. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173 3 (2004) 1834-1841
58. Vescovini R., Biasini C., Fagnoni F.F., Telera A.R., Zanlari L., Pedrazzoni M., Bucci L., Monti D., Medici M.C., Chezzi C., Franceschi C., and Sansoni P. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J. Immunol. 179 6 (2007) 4283-4291
59. Vlad G., Cortesini R., and Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J. Immunol. 174 10 (2005) 5907-5914
60. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 4 (2005) 338-344
61. Voskoboinik I., Smyth M.J., and Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6 12 (2006) 940-952
62. Vukmanovic-Stejic M., Zhang Y., Cook J.E., Fletcher J.M., McQuaid A., Masters J.E., Rustin M.H., Taams L.S., Beverley P.C., Macallan D.C., and Akbar A.N. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116 9 (2006) 2423-2433
63. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., and Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc. Natl. Acad. Sci. U. S. A. 102 11 (2005) 4103-4108
64. Weihong L., Putnam A.L., Xu-yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., Clayberger C., Soper D.M., Ziegler S.F., and Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J. Exp. Med. 203 7 (2006) 1701-1711
65. Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Lofgren S., Nilsson B.O., Ernerudh J., Pawelec G., and Johansson B. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 60 5 (2005) 556-565
66. Wohl D.A., Zeng D., Stewart P., Glomb N., Alcorn T., Jones S., Handy J., Fiscus S., Weinberg A., Gowda D., and van der Horst C. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J. Acquir. Immune Defic. Syndr. 38 5 (2005) 538-544
67. Yamazaki S., Bonito A.J., Spisek R., Dhodapkar M., Inaba K., and Steinman R.M. Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 110 13 (2007) 4293-4302
68. Yue F.Y., Kovacs C.M., Dimayuga R.C., Parks P., and Ostrowski M.A. HIV-1-specific memory CD4+ T cells are phenotypically less mature than cytomegalovirus-specific memory CD4+ T cells. J. Immunol. 172 4 (2004) 2476-2486
69. Zheng Y., and Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8 5 (2007) 457-462
70. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 7130 (2007) 936-940